The relationship between body mass index and survival in patients with renal cell carcinoma treated with nivolumab
{{output}}
Introduction: Immunotherapies have increased the therapeutic options for patients with metastatic renal cell carcinoma (mRCC), but the absence of prognostic indicators remains unresolved. We assessed the potential association of ... ...
